Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2013, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2013-07-17
DOI
10.1155/2013/437576
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction between CX3CL1 and CX3CR1 Regulates Vasculitis Induced by Immune Complex Deposition
- (2013) Sohshi Morimura et al. AMERICAN JOURNAL OF PATHOLOGY
- Identification and Functional Study of Cytokines and Chemokines Involved in Tumorigenesis
- (2012) Jun Zeng et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis
- (2012) Atsuko Taki et al. CONGENITAL ANOMALIES
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation
- (2011) S Kuc et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- In vivo structure/function and expression analysis of the CX3C chemokine fractalkine
- (2011) K.-W. Kim et al. BLOOD
- Microvascular Modifications in Diabetic Retinopathy
- (2011) Jennifer T. Durham et al. Current Diabetes Reports
- Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
- (2011) Anna K. Clark et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Placental immunology and maternal alloimmune responses
- (2011) B. M. Kumpel et al. VOX SANGUINIS
- Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential
- (2010) Jan G D'Haese et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
- (2010) B. A. Jones et al. MOLECULAR INTERVENTIONS
- CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1
- (2010) Giuseppe Sciumè et al. NEURO-ONCOLOGY
- Local regulation of implantation at the human fetal-maternal interface
- (2009) Evdokia Dimitriadis et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Vascular dysfunction in the diabetic placenta: causes and consequences
- (2009) Lopa Leach et al. JOURNAL OF ANATOMY
- Immune cells and angiogenesis
- (2009) Domenico Ribatti et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes
- (2009) Martha Lappas et al. JOURNAL OF ENDOCRINOLOGY
- Placental pathology in women with gestational diabetes
- (2008) George Daskalakis et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia
- (2007) J. Ryu et al. CARDIOVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now